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Summary
The mRNA-cleavage step of RNA interference is me-
diated by an endonuclease, Argonaute2 (Ago2), within
the RNA-induced silencing complex (RISC). Ago2
uses one strand of the small interfering (si) RNA du-
plex as a guide to find messenger RNAs containing
complementary sequences and cleaves the phospho-
diester backbone at a specific site measured from
the guide strand’s 5 end. Here, we show that both
strands of siRNA get loaded onto Ago2 protein in Dro-
sophila S2 cell extracts. The anti-guide strand be-
haves as a RISC substrate and is cleaved by Ago2.
This cleavage event is important for the removal of
the anti-guide strand from Ago2 protein and activa-
tion of RISC.
Introduction
RNA interference (RNAi) is a gene-silencing process
during which endogenous messenger RNA is destroyed
upon introduction of the corresponding double-stranded
RNA (Fire et al., 1998). RNAi has found widespread appli-
cation as a technique within research laboratories al-
lowing simple yet effective knockdown of genes of in-
terest (reviewed by Dykxhoorn et al. [2003]; Meister and
Tuschl 2004). Biologically, RNAi-related processes are
critical for development (Brennecke et al., 2003; Giral-
dez et al., 2005; Lee et al., 1993; Reinhart et al., 2000;
Rhoades et al., 2002), heterochromatin formation (Mo-
tamedi et al., 2004; Verdel et al., 2004; Volpe et al.,
2002), and offer cellular protection from virus (Baul-
combe, 2004; Vaucheret et al., 2001) and transposon
proliferation (Sijen and Plasterk, 2003).
The initiation event for the RNAi pathway is cleavage
of double-stranded RNA into small interfering RNAs by
an enzyme called Dicer (Carmell and Hannon, 2004). In
Drosophila, after being generated by a specific Dicer
enzyme, Dicer-2, the small interfering RNA binds to the
Dicer-2/R2D2 (D2/R2) complex (Liu et al., 2003). Forma-
tion of this complex precedes and is essential to RISC
formation in vitro and in vivo (Liu et al., 2003; Pham et
al., 2004; Tomari et al., 2004a). Interestingly, the D2/R2
complex orients the siRNA duplex so that the 5# end
with lower melting temperature preferentially interacts
with D2 (Tomari et al., 2004b). This orientation allows
the strand with its 5# end at the siRNA end with the*Correspondence: xwang@biochem.swmed.edulower melting temperature to become the single-
stranded guide RNA of RISC, which is held by Ago2
(Martinez et al., 2002). RISC uses the guide RNA to find
complementary mRNA sequences via Watson-Crick base
pairing and endonucleolytically cleaves the target mole-
cules phosphodiester bond between the tenth and elev-
enth nucleotide as measured from the guide strand’s 5#
end (Elbashir et al., 2001).
Recently, Ago2’s biochemical role within the RISC
complex was clarified when its PIWI domain was iden-
tified as RNase H-like by crystallography (Song et al.,
2004) and endonuclease V-like by a bioinformatics tool,
metaBASIC analysis (Rand et al., 2004). Importantly,
Ago2 was identified as the sole protein required for
mRNA cleaving RISC activity (Liu et al., 2004; Meister et
al., 2004; Rand et al., 2004). The endonucleolytic RISC
activity has also been demonstrated using bacterially
expressed human Ago2 loaded with a single-stranded
siRNA (Rivas et al., 2005).
How the double-stranded siRNA generated by D2/R2
complex gets loaded onto Ago2 protein and becomes
the single-stranded guide RNA is not clear. The pre-
vailing model addresses the loading of siRNA by invok-
ing a helicase activity. In this model, a helicase activity
is activated or recruited upon formation of the D2/R2/
siRNA complex (Meister and Tuschl, 2004). Three previ-
ous observations are consistent with the existence of a
helicase during RNA interference. First, siRNA-trig-
gered RISC activity was reduced upon removal of ATP
in a Drosophila embryo extract (Nykanen et al., 2001).
Helicases utilize ATP to separate the RNA strands. Sec-
ondly, though both double-stranded (ds) and single-
stranded (ss) siRNA (at higher concentrations) can acti-
vate RISC in cell extracts, only ss siRNA can be directly
loaded onto recombinant Ago2 (Nykanen et al., 2001;
Martinez et al., 2002; Rivas et al., 2005). Finally, though
their biochemical roles have not been demonstrated,
several helicases have been identified by genetic or
biochemical studies as potentially playing a part in
RNAi in various systems (Meister and Tuschl, 2004).
To illustrate the molecular mechanism of siRNA load-
ing onto RISC and its subsequent activation process,
we conducted a detailed biochemical analysis of this
process. Our results are surprising and as reported
here, suggest an alternative model for siRNA loading
and RISC activation.
Results
Loading and Activation of RISC Is ATP-Independent
in S2 Cell Extracts
In an effort to further understand the siRNA loading
mechanism of RISC, we depleted ATP from the S100
extracts prepared from Drosophila S2 cells by treating
the extracts with Hexokinase in the presence of 100
mM glucose. The removal of ATP was followed using
Sigma’s luciferase-based ATP assay. After treatment,
the ATP level remaining, 0.8 pM, was at the detection
limit of the kit (w2 pM) and orders of magnitude less
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622than the mock-treated extracts (data not shown). The
ATP-depleted extracts and mock-treated extracts (ad-
dition of glucose and buffer in place of Hexokinase sup-
plemented with 1 mM ATP) were then used to measure
mRNA-cleaving RISC activity and double-stranded
RNA-cleaving Dicer activity. As shown in Figure 1, when
compared to mock-treated extracts (+ATP lanes), the
ATP-depleted extracts (−ATP lanes) demonstrated com-
parable siRNA-induced RISC activity (upper panel). As
a control for ATP removal, we checked the Dicer activity
in the same samples (lower panel). The main Dicer ac-
tivity in S2 100,000 × g supernatant (S100) is Dicer-2,
which requires ATP to process dsRNA into siRNA (Liu
et al., 2003). The Hexokinase-treated extracts (−ATP
lanes, Figure 1, bottom panel) were deficient for Dicer
activity relative to the mock-treated sample (+ATP lanes,
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fFigure 1. Effect of ATP Depletion on RISC and Dicer Activities in S2
Cell Extracts
Cell extract preparation from S2 cells, ATP depletion, and RISC
assays were done as described in the Experimental Procedures.
Left top panel (+ATP) shows the let-7 siRNA-triggered RISC activity
time course (3, 10, 30 min as indicated above the lanes) in mock-
Hexokinase-treated S2 cell extracts supplemented with 1 mM ATP.
The RISC substrate (see label “RISC substrate” to the right, top
panels) is a radiolabeled, G-capped, w300 base long mRNA con-
taining a let-7 target sequence about 150 base pairs from the 5#
end. Similarly, the right top panel (−ATP) shows RISC activity in
Hexokinase-treated S2 extract. The lower panel shows the Dicer
activity time course (3, 10, 30 min as indicated above the lanes)
using the same extracts as described above. The Dicer substrate
(see label “dsRNA” to right of lower panels) is randomly radiola-
beled dsRNA w500 bases long. The Dicer activity was measured
as described in Liu et al. (2003).
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wigure 1, bottom panel), which demonstrated strong
icer activity. This result, together with the luciferase-
ased quantification of ATP, demonstrated that siRNA-
ctivated RISC activity is largely ATP independent in S2
xtract. This result does not support the requirement of
n ATP-dependent helicase in removing the anti-guide
trand during RISC activation.
nti-Guide Strand of siRNA Is Cleaved by Ago2
t the Ninth Position from the 5 Phosphate
n light of the intrinsic endonuclease activity of Ago2,
e entertained the possibility that the anti-guide strand
f siRNA was removed from RISC through cleavage by
go2 itself via the same ATP-independent cleavage
echanism used for mRNA substrates. The hypothe-
ized cleavage of the anti-guide RNA and the subse-
uent release of the cleaved fragment from RISC would
esult in the production of two fragments from the origi-
al 21 nucleotide anti-guide siRNA strand. The 5# frag-
ent, containing the 5# end phosphate, would be 9
ases long. The 3# fragment would consist of the re-
aining 12 bases. In an attempt to detect the 5# cleav-
ge product, one strand of the let-7 siRNA was radio-
hosphorylated with P32 and the other strand was
hosphorylated with nonradioactive phosphate (Figure
A). After loading onto RISC, the RNA was recovered
nd analyzed by urea/polyacrylamide gel electrophore-
is followed by phosphorimaging. As shown in Figure
B, no hint of cleavage product was detected (lane 11).
e reasoned that the failure to see this cleaved 9
ase fragment could be due to cellular RNase activities
hat readily degrade non-G-capped, nonpolyadenyl-
ted small RNAs. To increase the likelihood of seeing
he small RNA product, we added 100-fold excess (rel-
tive to the siRNA) of a nuclease-resistant, 2#-O-meth-
lated, single-stranded RNA oligonucleotide that could
ase pair with the radiolabeled product once it was re-
eased from its complementary siRNA strand (as shown
n cartoon form in Figure 2A). Using this trapping tech-
ique, we easily detected a radiolabeled RNA (Figure
A, lanes 1–4) that perfectly comigrates with a radiola-
eled synthetic RNA 9-mer of the same sequence (Fig-
re 2A, lanes 5 and 10). A 2#-O-methylated RNA trap
onsisting of the complementary sequence (UGA…) did
ot rescue the 9-mer, demonstrating that the trap was
orking by sequence-specific annealing, rather than,
or instance, clogging an RNA degradation pathway
Figure 2B, lane 12). Furthermore, the 9-mer RNA was
ompletely absent in reactions using Ago2 null fly ex-
ract indicating its production was Ago2-dependent
Figure 2B, lanes 6–9 compared to lanes 1–4). Using the
ame procedure except the siRNA was labeled at 3#
nd with 5# α-32P-pCp, the cleaved 3# 12-mer was also
bserved although the radio label is much less stable
han the 5# phosphate (see Figure S1 in the Supplemen-
al Data available with this article online).
Ago2 is known to cleave target RNAs leaving a 3#
ydroxyl and 5# phosphate at the site of cleavage (Mar-
inez and Tuschl, 2004). If the observed radiophosphor-
lated product is in fact generated by Ago2 cleavage,
t is predicted to contain a 5# phosphate and a 3# hy-
roxyl group. To test if the ends of the observed RNA
ragment had these functional groups, the radiolabeled
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(A) A cartoon of the siRNA used to detect 9-mer fragment production. The bottom strand (UGA…) was radiolabeled using P32 (designated
with “P*”) as described in Experimental Procedures, and the top strand (UAU…) was not radiolabeled (designated with “P”). Numbers are
provided on each strand to aid in counting bases from the 5# end of either strand. To conserve space, only the last digit is shown (10 = 0,
etc.). The predicted Ago2 cleavage site is designated with a black triangle between position 9 and 10 on the bottom strand. Below the siRNA
is a cartoon of the 2#-O-methylated “trap” strand annealed to the predicted 9-mer fragment. Note that the sequence of the trap is the same
as the top strand of the original siRNA (UAU…).
(B) Lanes 1–4 show a time course (0, 3, 10, 30 min) using embryonic extracts from wild-type (wt) fly prepared as described in the Experimental
Procedures after addition of the siRNA presented in (A). The RNA was recovered as described in Experimental Procedures and analyzed by
20% urea/polyacrylamide gel electrophoresis and visualized by autoradiogram. Lanes 6–9 show the same time course in Ago2 null fly extract.
Lanes 1–4, 5–9, and 12 contained a 100-fold excess (relative to the siRNA concentration) of trap. Lane 11 is identical to lane 4 only it lacks
trap. Lane 12 is identical to lane 4 except the trap sequence is the same as the lower strand in (A) (UGA…). Lanes 5 and 10 were synthetic
radiolabeled RNA with the same sequence as the fragment shown in cartoon (A).
(C) A T4 RNA ligation reaction using a synthetic 5# radiolabeled RNA (left panel) as substrate or gel extracted 9-mer (from the 9 base position
of lanes 3 and 4 as shown in [B]) as substrate in the right panel. Reactions were with ligase (+) or without ligase (−) as indicated; the reaction
was analyzed by 20% urea/polyacrylamide gel electrophoresis and visualized by autoradiogram.
(D) Time course of RISC activity measured in the absence or presence of trap. The RISC activity was measured as described in the Experimen-
tal Procedures. Lanes 1–4 (0, 10, 30, 60 min) demonstrated RISC activity without trap present. Lanes 5–8 (0, 10, 30, 60 min) measured the
RISC activity in the present of UAU trap.
(E) 9-mer formation from the siRNA shown in (A) using mock-Hexokinase-treated extract supplemented with 1 mM ATP (+ATP), or Hexokinase-
treated extract (−ATP) as described in Experimental Procedures. Time points are as indicated above each lane. Reactions were analyzed as
in (B). Lanes titled “M” contain the synthetic 9 base marker RNA.fragment was excised, gel extracted, and then used as
substrate in a T4-RNA ligase reaction. T4-RNA ligase
catalyzes a reaction wherein RNA ends are ligated to-
gether creating a phosphodiester bond between a 5#
phosphate and a 3# hydroxyl ends. In a control reaction
using a synthetic RNA with 5# phosphate and 3# hy-
droxyl, the addition of ligase resulted in the productionof a ligated radiolabeled product that ran faster than
the unligated substrate (see Figure 2C, left panel). The
faster migration is likely due to a self-ligated RNA spe-
cies (closed-circular), the most common product of li-
gation reactions. Likewise, the gel-extracted 9-mer
RNA fragment could also be converted to a faster mi-
grating ligation product, indicating that the RNA frag-
Cell
624ment contained 5# phosphate and 3# hydroxyl groups
(Figure 2C, right panel).
Ago2-dependent production of 9-mer from the anti-
guide strand could potentially occur subsequent to,
rather than during, the loading process. For instance,
after helicase-mediated strand separation, RISC might
relocate, anneal to, and cleave the previously liberated
anti-guide strand (the “reunion” model). Presumably, if
such a mechanism were to account for 9-mer forma-
tion, RISC activity would have to occur even in the
presence of trap. To check whether this was possible,
we performed RISC assays in the presence of UAU
trap. As shown in Figure 2D, RISC activity was com-
pletely lost in the presence of trap, while in the absence
of trap, there was normal RISC activity (Figure 2D, lanes
1–8). This indicates that there is a significant difference
between the anti-guide strand cleavage activity and the
mRNA cleavage activity of RISC—only the anti-guide
strand cleavage activity remains intact even with a
large excess of trap molecule present.
The cleaved anti-guide strand 9-mer was observed
at comparable levels with or without ATP (Figure 2E).
This is in agreement with the observation that ATP has
little effect on the total process of siRNA-triggered
RISC loading and activity as shown in Figure 1.
2-O-Methyl Modification Decreases 9-Mer
Production and RISC Activity
If anti-guide strand cleavage were important to the
activation mechanism, chemical modification at the
cleavage site would be predicted to inhibit RISC activ-
ity. 2#-O-methyl modification of ribose residues have
widely been used to site specifically block ribonuclease
activity including RISC activity toward RNA targets
(Martinez and Tuschl, 2004). The effect of 2#-O-methyl
inhibition is due to the ability of the methyl group to
cause steric hindrance of the Mg2+-based cleavage
mechanism (Schwarz et al., 2004). We incorporated this
chemical modification on base 9 of the anti-guide RNA.
To ensure that the chemically modified RNA would in
fact become the anti-guide, rather than the guide RNA,
we used an asymmetrical RNA with a bubble A-G mis-
match on one end as previously described (Tomari et
al., 2004b; see Figure 3A for the sequence). No RISC
activity against the anti-guide strand’s target was de-
tected (Figure 3C, lanes 1–9), whereas the RISC activity
generated by the guiding strand (green strand) was
readily detected (Figure 3B, lanes 1–9). As shown in
Figure 3B, the 2#-O-methyl modification at position 9 of
the anti-guide strand reduced the RISC activity of the
guide strand by over 50% (Figure 3B, lanes 1–3 com-
pared to lanes 4–6). When the modification was moved
to the neighboring position, base 8 from the 5# end of
the anti-guide strand, activity returned to the level of
unmodified siRNA (Figure 3B, lanes 1–3 and 7–9). Simi-
larly, the modification at the 10 position also had full
activity (data not shown). This indicates the sensitivity
to chemical modification was site specific and the ef-
fect was limited only to the predicted Ago2 cleavage
site. Though we find it plausible that a chemical modifi-
cation could also reduce loading in a helicase-depen-
dent mechanism, we think it unlikely that it would do
so site specifically. Consistently, compared to an un-
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2odified or 8-modified anti-guide-containing siRNA,
he 9 2#-O-methyl modification reduced anti-guide
trand cleavage activity as measured by 9-mer produc-
ion (Figure 3D). It is important to note that 9 modifica-
ion is does not completely block 9-mer formation. In
eneral, there is a good correlation between the reduc-
ion in RISC activity and 9-mer formation resulting from
he addition of the 2#-O-methyl modification at the 9
osition.
As demonstrated in Figures 3B and 3C, the green-
abeled strand is exclusively selected as the guide
trand of RISC. We checked to see if 9-mer fragments
ere produced from the guide as well as the anti-guide
trand. As shown in Figure 3E, 9-mer was only gener-
ted from the anti-guide (lanes 1–4), while the guide
roduced no detectable 9-mer (lanes 5–8).
We directly compared which causes a greater reduc-
ion in RISC activity in S2 cell extract—removal of ATP
r chemical modification of the anti-guide strand and
he results are shown in Figure 4. Unmodified siRNA
as loaded in mock-ATP-depleted extract containing 1
M supplemented ATP, and RISC activity was followed
ver time (Figure 4, left panel). Similarly, to measure the
ffect of ATP depletion, we used Hexokinase-treated
xtracts with unmodified siRNA (Figure 4, middle panel).
inally, the effect of the 9-2#-O-methyl modification in
he siRNA anti-guide strand was measured using the
ISC assay on mock-ATP-depleted extract containing
mM supplemented ATP (Figure 4, right panel). As
uantified in Figure 4B, it is apparent that ATP depletion
id not affect the initial loading of siRNA or RISC activ-
ty. However, over time ATP depletion began to have an
ffect. On the other hand, the 9-modification’s effect on
ISC activity was immediately apparent and remained
onstant throughout the time course.
go2 Interacts with the Anti-Guide Strand
f siRNA Transiently
ecause 2#-O-methyl 9 modification of the anti-guide
trand of siRNA reduces RISC activation, we attempted
o detect an increased interaction between the endoge-
ous nuclease-active Ago2 with modified siRNA. Using
he same modification strategy, we synthesized bio-
inylated unmodified, 9-modified, and 8-modified anti-
uide strands. The biotin modification of 3# hydroxyl
roup of either the guide or anti-guide strand of siRNA
oes not affect RISC activity (Martinez et al., 2002 and
ata not shown). Each of these anti-guide strands was
nnealed to a nonbiotinylated guide strand. Likewise,
e synthesized a biotinylated guide strand, which
as annealed to nonbiotinylated unmodified, 9-modi-
ied, or 8-modified anti-guide RNAs. Each of the six
iRNAs was then added into two types of S2 cell ex-
racts. The first type of extracts contained HisFlagAgo2
s well as the endogenous Ago2 protein. The second
ype of extracts contained exogenously expressed His-
lag-tagged Ago2 containing a D965A active site muta-
ion (again, in addition to the endogenous Ago2). The
965 position of Drosophila Ago2 is part of a well-con-
erved GADV motif previously demonstrated to be re-
uired for nuclease activity in human Ago2 (Liu et al.,
004).
As shown in Figure 5, when biotinylated guide strand-
Ago2 Cleaves siRNA Anti-Guide Strand
625Figure 3. Site-Specific Effect of Chemical
Modification on the Anti-Guide RNA Strand
(A) The sequence of the asymmetric siRNA,
G+@G as previously described in Tomari et
al. (2004b). They were used in Figures 3, 4,
and 5. The strand predicted to become the
guiding strand for RISC is colored green and
labeled “G, guide.” The strand predicted to
be excluded from active RISC is colored red
and labeled “@G, anti-guide.” Note the GA
bubble at the 5# end of the green strand.
(B) Guide strand (green) RISC activity over
time using three different siRNAs: unmodi-
fied (lanes 1–3), 9-2#-O-methylated anti-guide
strand-containing siRNA (lanes 4–6), and 8-2#-
O-methylated anti-guide strand-containing
siRNA (lanes 7–9). The RISC substrate in (B)
contains a target site complementary to the
green strand. The RISC assays were carried
out as described in Experimental Procedures.
RISC substrate and product sizes are indi-
cated to the left. Lanes 1, 4, and 7 are 13
min reactions; lanes 2, 5, and 8 are 40 min
reactions; and lanes 3, 6, and 9 are 120 min
reactions.
(C) The anti-guide strand (red) RISC activity
by performing the same experiment as shown
in (B) but exchanging the RISC substrate for
one that contains the red strand target se-
quence is shown.
(D) 9-mer production from the various (unmod-
ified, 9-modified, and 8-modified) anti-guide
strands (see cartoon above panel, * indicates the position of the radiolabel) is shown. Lanes 1, 5, and 9 are 0 min reactions; lanes 2, 6, and
10 are 13 min reactions; lanes 3, 7, and 11 are 40 min reactions; and lanes 4, 8, and 12 are 120 min reactions. “M” indicates 9 base marker
in panels (D) and (E).
(E) 9-mer production measured from the anti-guide (lanes 1–4) and guide (lanes 5–8) strand. Time points 1–8 are as described in (D). * in
cartoon above the panel indicates the position of the radiolabel in the siRNAs.Figure 4. Comparison of the Effect of ATP Depletion versus siRNA Modification on RISC Activity
(A) Left, middle, and right panels show the RISC activity over time using unmodified (UN) siRNA with ATP (+ATP), unmodified siRNA without
ATP (−ATP), or 9-modified (9-mod) siRNA with ATP (+ATP), respectively. As indicated, the siRNAs used are the same as the unmodified and
9-modified asymmetric siRNAs used in Figure 3. RISC substrate (w300 base target mRNA) and RISC product (w150 base cleavage product)
sizes are designated to the right of the phosphoimage. From left to right, the lanes in each panel are 10, 20, 40, 80, and 120 min reactions, re-
spectively.
(B) Triplicate experiments as shown in (A), graphed as percentage of maximum product versus time (min). Percentage maximum product was
calculated as product (P)/(substrate [S] + P)/(Pm/Pm + Sm) fraction from most processed lane (UN, 120 min, +ATP). Pm is the maximum
product generated after 120 min incubation in the presence of ATP using unmodified substrate. Sm is the substrate left in that reaction. Blue
line with circles indicates the unmodified, +ATP reaction time course. Gray triangles indicate the unmodified, −ATP reaction time course. Red
squares indicate the 9-modified, +ATP reaction time course.
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626Figure 5. Guide and Anti-Guide Strand of siRNA Interact with Ago2
Six different siRNAs were generated. All six contain the same sequence as the siRNA shown in Figure 3A. The six siRNAs differed in (1) the
position of the modification (2#-O-methyl) on the anti-guide strand, either unmodified (UN), 9-modified (9), or 8-modified (8); and (2) the biotin
group placement on the 3# end of either the anti-guide (red) strand or guide (green) strand. Extracts (10 mg/ml) were prepared from S2 cells
stably expressing HisFlagAgo2 or HisFlagAgo2 (D965A) generated as described in Experimental Procedures. The six different siRNAs were
then used to load the two types of S2 extracts for 2 hr at 30°C and then the siRNA was pulled down using Streptavidin beads (see Experimen-
tal Procedures). The recovered protein was separated on 6% SDS-PAGE gel and analyzed by Western blot using an anti-Ago2 antibody as
described in Liu et al. (2003). Lane 1, marker HisFlagAgo2-purified protein expressed in yeast. The top panel shows the pull-down results
from siRNAs containing a biotinylated anti-guide strand. The bottom panel shows the results from the siRNAs containing a biotinylated guide
strand. Lanes 2 and 5, top and bottom panels, had no internal modifications (UN). Lanes 3 and 6, top and bottom panels, had the 9
modification (2#-O-methyl) on the anti-guide strand. Lanes 4 and 7, top and bottom panels, had the 8 modification on the anti-guide strand.
Lanes 2–4, top and bottom panels, were from the HisFlagAgo2 (D965A) (S2) extract. Lanes 5–7, top and bottom panels, were from the wild-
type HisFlagAgo2 (S2) extract. Positions of the endogenous Ago2 protein and the tagged (HisFlagAgo) proteins are designated on the left of
both the top and bottom panels.containing siRNA was used, the endogenous as well as
both forms of tagged, recombinant Ago2 got pulled
down (lower panels). In contrast, the anti-guide strand
pulled down wild-type Ago2 protein (endogenous as
well as the HisFlag-tagged recombinant protein) only
when it contained a 2#-O-methyl modification at the
ninth position (Figure 5, upper right panel, upper and
lower band). Unlike wild-type Ago2, the active site mu-
tant Ago2 was found to bind all three anti-guide strands
regardless of its modification status (Figure 5, upper left
panel, upper band).
Discussion
The above experimental results support a model for
how siRNA, generated from long double-stranded RNA
by Dicer enzyme, becomes the single-stranded guide
of Ago2 nuclease. It seems that both strands of siRNA
are loaded onto Ago2 and the anti-guide strand be-
comes the first substrate of Ago2. The cleavage and
subsequent disassociation of the anti-guide strand
fragments produces active RISC capable of targeting
cognate mRNA for endonucleolytic cleavage.
ATP Dependence of RISC Activity
The clue for this model originated from the lack of ATP
requirement in siRNA activated RISC activity in S2 cell
extracts. We observed almost normal siRNA induced
RISC activity in extracts prepared from Drosophila S2
cells in which ATP was depleted to a very low level.
This result argued against the requirement for an ATP-
dependent helicase that unwinds the two strands of
siRNA to form functional RISC. In 2001, Nykanen et al.
(2001) published a seminal description of the ATP
requirements in RNA interference using Drosophila
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tmbryo extracts. First, ATP was found to be required
or the formation of siRNA from dsRNA. This ATP
equirement is also found in S2 cell extracts. Second,
TP was found to be required for siRNA to become sin-
le stranded and for RISC activity. In contrast, this
equirement appears to be absent from S2 cell extract
Figure 1). One potential reconciliation of this observed
ifference could be that there is a more prominent
hosphatase activity in Drosophila embryonic extracts
hat rapidly dephosphorylates exogenously add siRNA
uplexes (Nykanen et al., 2001). In this case, ATP would
e necessary to allow the dephosphorylated siRNA to
eenter the RNAi pathway via phosphorylation by an
ndogenous kinase (Nykanen et al., 2001). In contrast,
he 5# phosphate of siRNA in S2 extracts is rather sta-
le. The small amount of ATP enhancement seen in S2
ell extracts is consistent with a weak phosphatase ac-
ivity because early on (before the phosphatase has
ime to dephosphorylate many of the siRNAs) the
iRNA population is observed to load normally resulting
n full RISC activity (Figure 4B). However, in later time
oints, dephosphorylated siRNAs might accumulate,
hereby dropping the effective concentration of siRNA.
TP would be needed to replenish the siRNA pool
hrough a nucleotide kinase. Of course, we cannot rule
ut the possibility that there is a much more active heli-
ase in the Drosophila embryonic extracts that unwinds
iRNAs before they are cleaved by Ago2. In any case,
t least in S2 cell extracts, RISC can be activated by
iRNA even when ATP was depleted.
oth Strands of siRNA Interact with Ago2
he ATP independence of RISC activation by siRNA
uggested that both strands of siRNA might get passed
o Ago2 from D2/R2/siRNA complex without being sep-
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627arated by a helicase. Indeed, using a 3# biotin-modified
siRNA, we detected interaction between both strands
of siRNA and Ago2 protein (Figure 5). As predicted, the
interaction between the guide strand and Ago2 was
readily detected. However, the anti-guide strand and
Ago2 interaction was only detected when we used the
2#-O-methyl-modified siRNA at the ninth position or
when an active-site mutant Ago2 protein was used.
Since in both cases, the cleavage of anti-guide strand
is impaired, it seems to us that the cleavage event is
important for the anti-guide strand to leave Ago2 and
therefore activate RISC to cleave mRNA substrates.
Ago2 Cleaves the Anti-Guide Strand of siRNA
If both strands of siRNA get loaded onto Ago2 protein
without separation, it is logical that the anti-guide
strand will be cleaved by Ago2 endonuclease since it
could closely mimic the mRNA substrate, differing only
in length. However, direct detection of cleaved prod-
ucts from the anti-guide strand was not possible be-
cause of its instability and was only observed when a
chemically modified single-stranded RNA “trap” that
annealed to and protected it from degradation was
used. The cleavage is ATP independent and occurs at
the 9-10 bond counting from the 5# phosphate of the
anti-guide strand (or alternatively, if counting from the
guide strand’s 5# end, across from the guide strand’s
10-11 bond). The cleaved product contains a 5# phos-
phate and a 3# hydroxyl group since it can be ligated
by T4 RNA ligase. Furthermore, the cleavage fragment
was not produced in Ago2 null fly extracts. These fea-
tures are consistent with the notion that the cleavage
is executed by Ago2 endonuclease.
In theory, the anti-guide strand might be cleaved after
it is peeled away from the guide strand during loading
and then hunted down by active RISC—in essence as
a RISC substrate. However, the interaction of each sub-
strate (mRNA versus anti-guide strand) with RISC is dif-
ferentiated upon the addition of trap. Only the anti-
guide strand, and not mRNA, can be cleaved in the
presence of trap. This difference can be explained by a
model where siRNA is introduced intact to Ago2 during
RISC activation because trap would not have access
to the guide strand sequence until after the anti-guide
strand has been cleavaged.
Is Anti-Guide Strand Cleavage Only for the Nuclease
Competent Argonaut Proteins?
Ago2 is one member of a large family of PAZ- and PIWI-
domain containing proteins. These proteins are found
in the genome of many organisms as evolutionarily di-
verse as archaebacteria and humans. We are just be-
ginning to learn about the various biological utilities of
these proteins, but they have already been implicated
in microRNA-regulated developmental processes, het-
erochromatin formation, stem cell maintenance, and of
course, RNA interference (Meister and Tuschl, 2004).
Evidence is mounting that many of these proteins use
guide RNAs to perform their cellular functions. Do
these proteins undergo a similar loading process in-
cluding cleavage of the anti-guide strand? It is thought
that the small, noncoding, imperfectly base-paired hair-
pin microRNAs are processed by Dicer to form siRNA-like species. Such a species would differ from siRNA in
that there would be bubbles where mismatches occur.
Mismatches between the guide and target RNA have
been shown to decrease RISC cleavage activity against
mRNA targets when the bubble occurs close to the
cleavage site (Martinez and Tuschl, 2004). This argues
that certain microRNAs will not be cleaved by their re-
spective Ago proteins during the loading process. Of
course, the mismatch bubbles might serve the same
function as cleavage by helping to decrease the overall
melting temperature of the duplex. Nevertheless, family
members such as human Ago1, 3, and 4 lacking the
nuclease activity will be unable to cleave the anti-guide
RNA no matter what level of complementarity the two
strands have. Considering this, it seems likely that
there will be alternative solutions for removing certain
anti-guide miRNA strands.
Experimental Procedures
Extract Preparation
Drosophila embryo extracts were prepared by collecting embryos
that were 0–2 hr old. Embryos were washed in chilled water and
then resuspended in buffer A (10 mM HEPES [pH 7.4], 10 mM KAc,
2mM MgAc, 5 mM DTT, Complete protease inhibitor [Roche]),
dounced 40 times followed by centrifugation at 100,000 × g. The
supernatants were collected, aliquoted, frozen in liquid nitrogen,
and stored at −80°C. S2 cell extracts were prepared similarly but
washed with PBS (instead of water). Cells were grown in HyQ
(Hyclone) insect cell media at 27°C, in suspension using shaker
flasks and maintaining the density between 4 and 25 million cells/ml.
siRNA Preparation
siRNAs (Dharmacon) were phosphorylated using T4 polynucleotide
kinase (PNK; NEB). siRNAs were either unlabeled or radiolabeled
depending on which strand was to be visualized. Briefly, 20 M
single-stranded siRNA was incubated in a 50 l reaction volume
containing 1× PNK buffer, 50% PEG-8000 solution (10% w/v), 10 U
PNK (10 U/l) containing either 1 mM ATP or 5 l (0.05 mCi) of γ
32P ATP (Molecular Probes; for radiolabeling reactions). The phos-
phorylation reactions were incubated at 37C° for 1 to 2 hr. Reac-
tions were heat inactivated. Strands to be annealed were mixed at
equal concentrations, placed in a 90°C water bath, and allowed to
cool to room temperature. Annealed siRNAs were then run on a
16% nondenaturing acrylamide gel at 130V for 90 min at 4°C and
then gel purified, ethanol precipitated (in the presence of glyco-
gen), washed in 70% ethanol, briefly air dried, and resuspended in
DEPC water to a final concentration of 20 M. Radiolabeled siRNAs
were then further diluted to give 25,000 cpm/l. Specific siRNAs
(Dharmacon) used were as follows:
let-7—5#-P-UGAGGUAGUAGGUUGUAUAUU-3# and 5#-P-UAU
ACAACCUACUACCUCAUU-3#; G+@G,
G—5#-P-GUCACAUUGCCCAAGUCUCUU-3# and @G: 5#-P-GAG
ACUUGGGCAAUGUGAAUU-3#.
Modified siRNAs were as follows:
@Gm8—5#-P-GAGACUUmGGGCAAUGUGAAUU-3#,
@Gm9—5#-P-GAGACUUGmGGCAAUGUGAAUU-3#,
@Gm10—5#-P-GAGACUUGGGmCAAUGUGAAUU-3#,
UGA trap was as follows:
5#-P-mUmGmAmGmGmUmAmGmUmAmGmGmUmUmGmUm
AmUmAmUmU-3#;
UAU trap was as follows:
Cell
6285#-P-mUmAmUmAmCmAmAmCmCmUmAmCmUmAmCmCm
UmCmAmUmU-3#,
G-bio—5#-P-GUCACAUUGCCCAAGUCUCUU-biotin-3#,
@G-bio—5#-P-GAGACUUGGGCAAUGUGAAUU-biotin-3#,
@Gm8-bio—5#-P-GAGACUUmGGGCAAUGUGAAUU-biotin-3#,
@Gm9—5#-P-GAGACUUGmGGCAAUGUGAAUU-biotin-3#,
@Gm10—5#-P-GAGACUUGGGmCAAUGUGAAUU-biotin-3#
(“m” indicates the 2#-O-methylated residue and is added before
the modified base).
RISC Assay
Target mRNAs were synthesized using an in vitro transcription kit
(Mega Script, Ambion) from a PCR template produced from a pGL3
(Clontech) vector containing the let-7, G, or @G target sequences.
The mRNA was purified by quenching the reaction with 200 l of 7
M urea/0.3 M NaOAc stop solution followed by extraction with 100
l phenol/chloroform/isoamyl alcohol. The aqueous phase was
then run through a G50 column (Amersham) to remove unincorpo-
rated nucleotides and then ethanol precipitated. The mRNA was
then resuspended to a stock concentration of 2 g/l. mRNA was
then G-capped with (α 32P) GTP (3000 Ci/mmol, Molecular Probes)
using Guanylyl Transferase (Ambion). The reaction was done in a
30 l volume using 4 g mRNA for 2 hr at 37°C. Purification was
done in an identical manner as that for the initial in vitro transcrip-
tion step except that the product was then run on a 6% urea-acryl-
amide gel for 15 min at 300V and then gel purified and ethanol
precipitated. The labeled mRNA was then diluted to 100,000 cpm/
l. 1 l per reaction was typical for the RISC assays.
The RISC assay has been previously described by Liu et al.
(2003). Briefly, in a total volume of 10 l, 5 l of S2 extracts (10 mg/
ml) was incubated with 1 mM ATP, 1× Buffer 12 (10× Stock: 50 mM
HEPES [pH 7.4], 25 mM DTT, 10 mM MgAc, 1050 mM KAc), 20 U
RNase Inhibitor (20 U/L) (Ambion), 25 nM 5# phosphorylated
siRNA and radiolabeled target mRNA (100,000 cpm) for the indi-
cated times at 30°C. Reactions were quenched with 200 l 7 M
urea/0.3 M NaOAc stop solution and extracted with 100 l phenol/
chloroform/isoamyl alcohol. The aqueous phase was then ethanol
precipitated and the resulting pellet was washed in 70% ethanol
and allowed to dry. The pellet was then resuspended in formamide
loading dye (Ambion) and boiled for 5 min. Samples were loaded
onto a 6% acrylamide/7 M urea gel and run at 300V for 20 min. The
gel was then exposed to an X-ray film (Kodak) for 1 hr at −80°C.
ATP Depletion
ATP was depleted from S2 extracts using Hexokinase (1 U/10 l
extract, Sigma) and 100 mM glucose. Mock-treated samples were
identical, except that buffer A was used instead of Hexokinase.
Treated extracts were incubated for 20 min at RT and then placed
on ice prior to use (within 60 min). An aliquot was used to measure
ATP content. ATP was measured using a luciferase based assay
(Sigma), according to the manufacturer’s protocol using a standard
curve measured at the time the depleted samples were measured.
Anti-Guide Cleavage Assay
9-mer fragment production was measured in either Drosophila S2
S100 or Drosophila embryo S100 under conditions similar to the
RISC assay (Liu et al., 2003). Briefly, 9-mer generation was done in
30 l reaction volumes at 30°C in 1mM ATP, 1× Buffer 12, 60 U
RNase Inhibitor, 3.3 M 2#-O-Me Trap, 25 nM siRNA (5# radiola-
beled and set to 25,000 cpm). Purification and loading of the sam-
ples was identical to the RISC assay except that a 20% acrylamide/
7 M urea gel was used and the samples were run on a Hoefer SE
400 series gel electrophoresis unit (14 × 16 cm glass plates) at 25
mA for 60 min. The gel was then exposed to an X-ray film (Kodak)
for approximately 15 hr at −80°C.
Biotinylated siRNA Pull-Downs
Aliquots of 150 l S2 cell extracts (10 mg/ml) were loaded with
siRNA containing a biotin group on the G or @G strand as indicated
in the Results section. Loading was performed as a standard RISC
assay (minus the target RNA), for 2 hr at room temperature. The
reactions were then placed on ice, diluted with 1 ml chilled PD
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euffer (buffer A, 100 mM NaCl, 1% TX-100). Suspended Novagen
treptavidin beads (100 l suspended slurry, 35 l packed volume)
ere added, and the reactions were rotated at 4°C overnight. The
eads were then washed 5 times with PD buffer, spun down, and
arefully aspirated to remove all excess liquid. The beads were re-
uspended in 60 l of 4× SDS-PAGE sample buffer. Aliquots of 30
l were loaded for Western blot on a 6% SDS-PAGE gel. The West-
rn blot was detected using a polyclonal anti-Ago2 antibody, as
escribed in Liu et al. (2003).
2 Stable Cell Lines
MT HisFlagAgo2 and HisFlagAgo2 (D965A) constructs pMT (Invi-
rogen) were modified by replacing the existing polylinker with a
ew linker using the Kpn1 and Age1 sites. The oligos used for the
ew linker were pMT MCS2-1 (5#-CTCAGTCTAGAAAAGCCATGGT
AGCATATGTCAGGCGGCCGCTCAGAGGCC) and pMT MCS2-2
(5#-TCTGAGCGGCCGCCTGACATATGCTGACCATGGCTTTTCTAGA
TGAGGTAC). The new linker contained an Xba1 and a Not1 site.
hese sites were used to clone in HisFlagAgo2 and HisFlagAgo2
D965A) from pFastBacAgo2 constructs (F.D. and T.A.R., unpub-
ished data). The HisFlag tag contained the following amino acids:
GSSHHHHHHSSGLVPRGSHMDYKDDDDKG directly preceding
go2’s start codon. The pMT His-Flag-Ago2 construct was cot-
ansfected with pIB-V5His (Invitrogen) construct at a ratio 1:50 into
× 106 S2 cells grown in HyQ SFX-INSECT medium (Hyclone)
sing Cellfectin transfection reagent (Invitrogen) according to the
anufacturer’s protocol. After 60 hr, the cells were selected with
0 g/ml blasticidine for 3 weeks. The expression of Ago2 was
nduced by 500 M CuSO4 for 24 hr and confirmed by Western blot
sing a polyclonal anti-Ago2 antibody.
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rticle online at http://www.cell.com/cgi/content/full/123/4/621/DC1/.
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